Navigation Links
Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
Date:8/20/2009

A recent New York Times article, ''Senator Moves to Block Medical Ghostwriting,'' raises a heinous accusation, that Wyeth paid medical ghostwriters to suppress clinical evidence linking the use of synthetic hormone drugs to an increased risk of breast cancer.

Jacksonville, Fla. (Vocus) August 20, 2009 -- A recent New York Times article, ''Senator Moves to Block Medical Ghostwriting,'' raises a heinous accusation, that Wyeth paid medical ghostwriters to suppress clinical evidence linking the use of synthetic hormone drugs to an increased risk of breast cancer.

"I am gratified that the truth may finally be coming to light," said C.W.Randolph, Jr., M.D., "Even after the 2002 National Institutes of Health, Women's Health Initiative Trial (WHI) irrefutably established that synthetic hormones (such as the popularly prescribed Premarin family of products) caused the risk of breast cancer to increase 26 percent, physicians continued to prescribe these drugs putting millions of women's lives in jeopardy. Why? Because they were misled by pharmaceutical-sponsored medical studies skewing the facts."

According to Dr. Randolph, a nationally recognized medical expert in the field of natural, or Bioidentical Hormone Replacement Therapies (BHRT), this type of evidence has existed for decades.

As early as 1941, Edgar Allen, M.D., Chair of Yale Medical School Anatomy Department, published an article in the medical journal Cancer Research on the propensity of estrogen to cause cancer in animals. Since that time, the output of medical research and clinical studies continued to mount until, in 2001, representatives from the National Cancer Institute and the National Institutes of Health (NIH) voted 8-1 to add synthetic estrogen to the nation's list of cancer-causing agents.

Recent revelations that Wyeth directed DesignWrite medical ghostwriters to deliberately deemphasize the links between synthetic hormone replacement therapies and breast cancer in published medical journals are bringing experts in the field of BHRT to answer the question of the purpose for manipulating this data.

''Because there is big money at stake,'' says Genie James, M.M.Sc., Executive Director of the Natural Hormone Institute. ''Prior to the WHI findings being made public in 2002, the Premarin-family of products was a 2.2 billion dollar pipeline.''

According to an article in The New York Times, since 2002, sales for Wyeth's Premarin family of products have plummeted 50 percent, and have continued to decline over the last several years.

Research in the U.S. and around the world supports BHRT as the treatment of choice for menopausal symptoms and conditions of hormone imbalance.

"The sad reality is that when marketing gets ahead of medical science, women's lives are put at risk," says James.

About C.W. Randolph, Jr., M.D.: Randolph is an internationally renowned expert in the field of bio-identical hormone replacement. He is a board-certified obstetrician and gynecologist who practiced as a compounding pharmacist. He is the co-founder of the Natural Hormone Institute, a Diplomat of the American Board of Holistic Medicine, and a member of the International Academy of Compounding Pharmacists. He coauthored ''From Belly Fat to Belly Flat, From Hormone Hell to Hormone Well,'' and ''In the Mood Again'' (Simon & Schuster 2010).

About Genie James, M.M.Sc.: Genie is nationally acknowledged as a change-agent for improved women's health. She is the co-founder and executive director of the Natural Hormone Institute. She coauthored ''From Belly Fat to Belly Flat, From Hormone Hell to Hormone Well,'' and ''In the Mood Again'' (Simon & Schuster 2010).

Media Contact
Nanette Noffsinger
Burke Hollow Media
(615) 776-4230
nanette(at)burkehollowmedia(dot)com

###

Read the full story at http://www.prweb.com/releases/Breast_Cancer/Synthetic_Hormones/prweb2777324.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U.S. License and Collaboration Agreement
2. Statement from the American College of Surgeons Regarding Recent Comments from President Obama
3. Noted Vertebroplasty Expert Cites Concerns About Recently Published Study
4. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
5. The Obesity Society Position on Recent Criticism of Surgeon General Nominee Regina Benjamin
6. Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading: Studies Actually Show it is Effective at Reducing Pain
7. ReGen Biologics Clarifies Recent Press about the Menaflex Device
8. Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
9. PracticeMatch Releases Results of Recent State of the Industry Survey of Physician Recruiters
10. Recently Released Data from the National Survey of Childrens Health Reports That Autism Now Affects 1% of Children and is More Common Than Childrens Cancer, Diabetes, and AIDS Combined.
11. American Association for Homecare Sets the Record Straight About Recent Home Medical Equipment Issues in the News
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
(Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... over 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion ...
(Date:2/12/2016)... ... 2016 , ... Coco Libre, the maker of coconut water beverages with a ... Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut ... invitation-only gifting suite, held this year at the W Hollywood Hotel, has become a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman ... John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, ... VA Southern Nevada Healthcare System. This will be the first Fisher House in ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young ... area, celebrates the beginning of the latest charity campaign in their community enrichment ... art. Donations to this worthy cause are currently being accepted at: http://artexpressioninc.org/ ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Kalifornien, 12. Februar 2016  Sequent ... der Aufnahme von Patienten für eine Studie zur ... Aneurysmen („WEB") speziell für die Behandlung von rupturierten ... , MD, Leiter der Neuroradiologie an der Universitätsklinik ... und Hauptprüfarzt der CLARYS-Studie hat den ersten Patienten ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
Breaking Medicine Technology: